NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions-Reference-Cited by-同舟云学术

NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions

Published:2017-09 Issue: Volume:19 Page:95-106
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Welters Alena¹²,Klüppel Carina¹,Mrugala Jessica³⁴,Wörmeyer Laura¹²,Meissner Thomas²,Mayatepek Ertan²,Heiss Christian⁵,Eberhard Daniel¹^ORCID,Lammert Eckhard¹³⁴

Affiliation:

1. Institute of Metabolic Physiology, Department of Biology; Heinrich Heine University; Düsseldorf Germany

2. Department of General Pediatrics, Neonatology and Pediatric Cardiology; University Children's Hospital Düsseldorf, Medical Faculty, Heinrich Heine University; Düsseldorf Germany

3. Institute for Beta Cell Biology, German Diabetes Center; Leibniz Center for Diabetes Research; Düsseldorf Germany

4. German Center for Diabetes Research, Helmholtz Zentrum München, Neuherberg; Düsseldorf Germany

5. Division of Cardiology, Pulmonology, and Vascular Medicine; Medical Faculty, Heinrich Heine University; Düsseldorf Germany

Funder

Heinrich-Heine-Universität Düsseldorf

CRC

Deutsche Forschungsgemeinschaft DFG

German Center for Diabetes Research (DZD e.V.)

German Diabetes Center (DDZ)

Bundesministerium für Gesundheit

Ministry for Innovation, Science and Research of North Rhine-Westphalia

Publisher